Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results

doi:10.4331/wjbc.v13.i2.47

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7324)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

447

WORD

HTML

2876

Figures (1-5)

333

Tables (1-1)

270

Sum=4025

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

402

Download

1570

Sum=1972

Publishing Process of This Article

Item

Count

Browse

408

Download

919

Sum=1327

Mar 27, 2022 (publication date) through Jan 9, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Biol Chem. Mar 27, 2022; 13(2): 47-65
Published online Mar 27, 2022. doi: 10.4331/wjbc.v13.i2.47

Table 1 Primer sequences used in the current study

Gene	Forward	Reverse	Size
HLA-G1	AGGAGACACGGAACACCAAG	CCAGCAACGATACCCATGAT	685
HLA-G5	AACCCTCTTCCTGCTGCTCT	GCCTCCATCTCCCTCCTTAC	895
HLA-G7	AACCCTCTTCCTGCTGCTCT	TTACTCACTGGCCTCGCTCT	331
GAPDH	AAGGGCCCTGACAACTCTTT	CTCCCCTCTTCAAGGGGTCT	244

Citation: Mallis P, Chatzistamatiou T, Dimou Z, Sarri EF, Georgiou E, Salagianni M, Triantafyllia V, Andreakos E, Stavropoulos-Giokas C, Michalopoulos E. Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results. World J Biol Chem 2022; 13(2): 47-65
URL: https://www.wjgnet.com/1949-8454/full/v13/i2/47.htm
DOI: https://dx.doi.org/10.4331/wjbc.v13.i2.47